This is a profile image of Parag Patel

Parag Patel


Parag Patel


Serves pharmaceutical and medical-device companies and has experience across a broad range of topics such as operations, strategy, pricing, post-merger management, and marketing and sales effectiveness

Parag is a partner in McKinsey’s Chicago office. Since joining McKinsey, Parag has primarily served pharmaceutical and medical-products (PMP) companies across a broad range of topics such as operations, strategy, pricing, post-merger management, and marketing and sales effectiveness. Parag has deep expertise on operations topics such as digital and analytics, manufacturing strategy, supply-chain management, lean operations, product development, quality and risk assessment, and procurement. In addition, Parag leads McKinsey’s work in manufacturing strategy for North America, as well as our work in digital and analytics for PMP operations, globally.

Examples of his work include the following:

  • leading a broad-based operations transformation of a generics pharmaceutical business, including supply chain, planning, manufacturing, and quality
  • supporting a manufacturing-network-optimization effort for a pharmaceutical company to streamline operations; the effort included productivity, OH, overall equipment effectiveness, and strategic outsourcing decisions
  • partnering on a supplier quality-management improvement effort at a large medical-device company. Assessed sources of risk, prioritized focus areas, developed supplier assessment and performance monitoring tools, developed high-level organizational structure and size, developed internal practices
  • developing lean operations diagnostic at a manufacturing plant to identify opportunities to improve efficiency across all plant functions, including manufacturing, quality, laboratory, engineering, maintenance, procurement, finance, safety, distribution, and management and administrative areas
  • leading post-merger integration effort at a large pharmaceutical company to prepare client to integrate assets acquired from two different companies. Effort included focus on commercial, manufacturing, and R&D functional areas

Prior to joining McKinsey, Parag worked for 7 years at Merck & Co. He has diverse experiences managing and leading multinational projects in manufacturing operations, technology transfer, new product development, supply chain, and program management in Singapore, the United States, and the United Kingdom.

Published work

Reimagining the future of biopharma manufacturing,” McKinsey & Company, October 2022

Four ways to make sure your pharma manufacturing strategy delivers value,” McKinsey & Company, March 2022

The risks and challenges of the global COVID-19-vaccine rollout,” McKinsey & Company, January 2021

Pharma operations: The path to recovery and the next normal,” McKinsey & Company, May 2020

Pharma operations: Creating the workforce of the future,” McKinsey & Company, April 2020

Manufacturing network strategy in a world of unprecedented change,” McKinsey & Company, September 2017

Supplier quality is up to you: Preventing problems through active collaboration,” McKinsey & Company, 2014


MIT Sloan School of Management

University of Pennsylvania
MS, chemical and biomolecular engineering

Cornell University
BS, chemical engineering